



Leadership is the art of getting someone else to do something you want done because he wants to do it.

Leadership is the art of getting someone else to do something you want done because he wants to do it.
Art
Business
Business
Digital
Co-designer
Marketing
Dr. Navneet Vats
Championing Purpose-Driven, Sustainable Business for a Greener Tomorrow 06. 14. 18.
Sustainable Chemistry Approaches in Pharmaceutical Manufacturing
Synthetic Biology Applications in Pharmaceutical Manufacturing
Championing Purpose-Driven, Sustainable Business for a Greener Tomorrow
Leading Livexpo requires deep focus managing shi ing market demands, naviga ng client rela onships, and ensuring opera onal efficiencies. But I believe effec ve leadership lies not in micromanagement, but in trust, delega on, and building empowered teams.
Morethanjustonecompany,Livexpohasgrownintoa movement.Withsustainabilityasitscompassand innovationasitsengine,Dr.Navneetandhisteamare activelyreshapinghowtheworldperceivescleanlinessand hygiene.
Balancingapurpose-drivenenterprisewithpersonallifeis nosmallfeat,andforNavneet,thisbalancestemsfrom discipline,purpose,andareliablesupportsystem. “Leading Livexpo requires deep focus managing shifting market demands, navigating client relationships, and ensuring operational efficiencies. But I believe effective leadership lies not in micromanagement, but in trust, delegation, and building empowered teams.” hesays.
Hehasconsciouslycreatedaworkculturethatvalues accountabilityandinnovation.Thishasenabledhimto maintainasenseofseparationbetweenworkandpersonal life,achallenging,butessentialpursuitformentalwellbeing. “Family is central to my life. My family remains my grounding force, offering unwavering encouragement through all phases of my entrepreneurial journey. I prioritize quality time with them through simple but meaningful rituals—like shared meals, quiet evenings, and occasional travel.” hesays.
Hisdailyroutinereflectsadeepcommitmenttobalance. Earlymorningplanning,disciplinedtime-blocking,and momentsofreflectionhelphimstayalignedandenergized. Moreimportantly,hisintrinsicmotivationcomesfrom Livexpo’smission.Theknowledgethathiswork contributestopublichealthandenvironmentalprotection providesastrongsenseofpurposethatsustainshim throughstress,setbacks,anduncertainty.
ToNavneet,lifeandworkareinterconnected.Theydraw fromthesamewellofvaluesandinspiration.Byensuring hisbusinessremainsanauthenticextensionofhisbeliefs, he’sabletochannelenergyratherthandepleteit,making roomforpersonaljoyandprofessionalexcellencetocoexist.
Dr.Navneethasalwaysharboredastrongappetitefor businessadrivethatstemsfromhisinnateloveforcreating value,solvingproblems,andgeneratingimpact. “Business for me isn’t merely about transactions or profits; it is about transformation.
I believe in nurturing teams, mentoring emerging leaders, and crea ng workspaces that balance purpose and performance. I find immense sa sfac on in turning ideas into tangible impact whether it’s a breakthrough in product formula on or a successful ins tu onal partnership.
psychology behind consumer choices, market behavior, and the strategy needed to launch, build, and sustain powerful brands.” hecommented
Hiscareergavehimopportunitiestoengageineverything fromproductlaunchestostrategicpivots,butitwasthe birthofLivexpothattrulyunleashedhisentrepreneurial spirit.Livexpoisn’tjustacompany,it’shisresponsetothe world’spressingneedforsustainableliving.Andthisform ofvaluecreationiswhatenergizeshim.Theexcitementof transformingeverydaynecessitieslikecleaningsolutions intovehiclesofsustainabilityisthekindofchallengehe thriveson.
Dr.Navneetisalsodrawntodynamicenvironments.The unpredictabilityofentrepreneurshipdoesn’tdeterhim,it fuelshim. “I see every risk as a learning opportunity, every failure as a steppingstone, and every success as a collective victory. My curiosity for emerging technologies and market shifts ensures I always keep looking ahead.” hesays.
Tohim,businessisaplatformforimpact,itisawayto innovate,uplift,andredefinetherules.
Hishungerisnottomerelygrowbuttogrowwith conscience,innovation,andpurpose.
WhatdrivesDr.Navneetathiscoreisapassiontobuilda betterworldthroughinnovation.Hedoesn’tjustwanttobe rememberedasasuccessfulbusinessmanbutassomeone whousedbusinessasaforceforgood.Thisphilosophy iswhatgaverisetoLivexpoanditseco-friendly productline,FRESHER.
Heisinspiredbythebeliefthatsustainablechoices shouldbeaccessible,effective,andscalable.His passionliesindevelopingalternativestotoxic, chemical-basedproductsandcreatingawareness amonginstitutions,organizations,andeveryday usersabouttheimportanceofclean,safe environments.Histeam’sinnovationsarenow activelyreducingchemicalfootprintsincritical areaslikedefenseservices,educationalinstitutions, hospitals,andpublictransportation.
Healsofindspassioninpeople. “I believe in nurturing teams, mentoring emerging leaders, and creating workspaces that balance purpose and performance. I find immense satisfaction in turning ideas into tangible impact whether it’s a breakthrough in product formulation or a successful institutional partnership.” hesays.
Beyondproducts,it’sthemovementthatmattersmostto him.Hislong-termvisionisnotonlytoscaleLivexpobut tohelpshiftconsumerculturetowardmoreresponsible choices.Forhim,thisismorethanamission—it’salegacy.
TheCOVID-19pandemicdisruptedtheworld,andLivexpo Ventureswasnotimmunetoitseffects.However,forDr. Navneet,thecrisisalsoamplifiedtherelevanceof Livexpo’smission.Ashygieneandhealthbecameglobal priorities,eco-friendlyandsafecleaningsolutionsfound theirplaceatthecenteroftheconversation.
Theinitialdaysofthepandemicwerechallenging.Supply chaindisruptions,deliverydelays,andinstitutional shutdownsposedrealobstacles.Butratherthanretreat,he andhisteamdoubleddownontheircorestrengths.They focusedonwhatthemarketneededmost—safe,skinfriendlysanitizersanddisinfectantsthatdidn’tcompromise onefficacy
Duringthiscriticaltime,Livexpoprioritized consistency,quality,andavailabilityover aggressivemarketing.Byensuring uninterruptedsupplytokeyinstitutions, especiallythoseservingonthefrontlineslike hospitals,thecompanybuiltsignificanttrust andgoodwill.
WhatmadeLivexpostandoutduringthe pandemicwasitscommitmenttoitsfounding principles.Thecompanydidn’tpivotfor profitpivotedtoserve.Andindoingso,it turnedaglobalcrisisintoamomentof reaffirmation,provingthatsustainability, integrity,andpurposearetimelessbusiness values.
Throughresilience,foresight,and commitmenttopublicwell-being,Dr. NavneetVatsnotonlyhelpedhiscompany survivethepandemicbutpositionedLivexpo asabeaconofresponsibleinnovationforthe post-COVIDera.
Thepharmasectorhasbeenatthejunctionofgreen
technologiesandenvironmentalstewardshipforthe pasttwoyears.Asthereisincreasingworldwide anxietyaboutclimatechange,pollution,andtheerosionof naturalresources,slowlythefocushasshiftedtowardsall industriesgettinggreenerintheir operations—pharmaceuticalsincluded.
SustainableChemistryhasbeenoneofthemostviable meansofgreeningthefuture.Thisstrategynotonly minimizesthedrug-producingenvironmentalimpactbut alsooptimizesefficiency,safety,andcost-effectivenessin thelongrun.
WhatisSustainableChemistry?
SustainableChemistry,orgreenchemistry,isthedesignof chemicalproductsandprocessesthateliminateorminimize theuseandgenerationofhazardoussubstances.Sustainable Chemistryfocusesoncreativityinenergyconsumption, materialconsumption,andwasteminimization.Inthe pharmaceuticalsector,SustainableChemistryisapplying measuresminimizingenvironmentaldamagewithout weakeningorenhancingthedrugeffectandquality manufactured.
Pharmaceuticalproductionisahigh-energyprocess. Historically,itentailshugeamountsofsolvents,electricity, andwater,andevenproducesheavychemicalwastes.Part ofthewasteproductsistoxicandharmfultohumanhealth andtheenvironment.Inaddition,thedisposalof pharmaceuticalwastehasalsobeenanissue,withresiduein waterbodies,impactingaquaticlifeandevenreaching humandrinkingwater
Withincreasedworldwidedemandfordrugsandmore stringentregulatoryenvironmentsforenvironmental conditionshavingplacedincreasingpressure,thedemand hasrisenforcleaner,greenertechnologies.Andthisis whereSustainableChemistrycanbeagame-changer—not asregulation,butasasolution.
MainCorePrinciplesofSustainableChemistryin Pharma
SustainableChemistrytopharmamanufacturingisallabout afewmaincoreprinciples:
• PreventionofWaste:Insteadoftreatingordisposing ofwasteafterithasbeengenerated,Sustainable Chemistrypromotespreventingthewasteinthefirst instance.Thisentailsensuringthatreactionconditions areoptimizedtoensuremaximumyieldofthetarget productandminimumbyproductsareformed.
• SaferSolventsandReactionConditions:Volatile organicsolvents(VOCs)serveasthesolventsinmost pharmaceuticalprocessingcases.Sustainable Chemistryencouragestheuseoflesstoxic,safer solventslikewater,supercriticalCO₂,orbio-based solvents.
• EnergyEfficiency:Processingunderambient pressureandtemperatureconditionssaves considerableenergyinput.Notonlyisthisgreenwith loweremissions,butthemanufacturingcostisalso minimized.
• RenewableFeedstocks:Wherefeasible,utilizationof renewablerawmaterialsratherthanfinitepetroleumderivedmaterialsisadesignprincipleofsustainable production.
• Catalysis:Utilizationofcatalystshasthepotentialto speedupchemicalreactionswithoutbeingusedup, enablinglowerenergyconsumptionandlowerwaste.
• DesignforDegradation:Medicinescanbedesigned todegradeintoharmlessmaterialwhenswallowed, notremainingintheenvironment.
Ahandfulofpharmaceuticalcompanieshavestarted implementingSustainableChemistryprincipleswithgreat success.Forinstance,Pfizercameupwithanalternative synthesisrouteforsertraline(ananti-depressant)that circumventedover60%ofwasteandsolvent.Inasimilar manner,Merckincorporatedenzymaticreactionsintheir processwhereinitreplacedclassicalchemicalstepswith biologically-sourcedcatalyststhatarecleanerandmore selective.
Othersignificantadvancesaretheutilizationofflow chemistry—atechniqueforconductingreactionswithina streamofcontinuouslyflowingliquidinsteadofinbatches. Besidesenhancingsafetyandscalability,itreduceswaste andthedangerofcontaminationtonil.Withtheadditionof automationandon-linemonitoring,flowchemistrycan improveeverystepinthedrugmanufactureprocessto highestsustainability.
PracticingSustainableChemistryisnotonlybetterforthe planet—thereisalsogoodbusinesssensebehindit.Saving energyandminimizingwastesavesoncostsofproduction, savingsthatcanbepassedonintheformoflower-cost medicines.Andhealthierworkingenvironmentssaveon illnessexposure,too.Brand-wise,thecompaniesthatfocus onsustainabilitycanestablishapositiveimageamong consumers,investors,andregulators.
Inaddition,SustainableChemistryalsointersectswith socialresponsibilityandpublichealthagendasonabroader level.Thepharmaceuticalcompaniescanhelplessenthe pollutionoftheenvironmentandtoxicemissions,thereby keepingtheenvironmentcleanandpollution-free,resulting incleanerairandwaterintheenvironmentssurrounding wheretheyoperate.
Thoughthenumerousbenefits,drugmanufacturingusing SustainableChemistryisnotdevoidofitsdisadvantages.
ThesearetheexpenseofR&Dbeingoutofreach,requiring sophisticatedmachinery,andregulatorybarriersthatcould retardprogress.Butwithsuccessstoriespilingupand technologyadvancingfurther,theseareslowlybeing dismantled.
Academia,industry,andgovernmentwillneedtowork together.Public-privatepartnerships,grants,andtaxcredits canenabletheshifttowardsustainablepractices.Workforce developmentprogramsandtrainingcanalsoteachthenext generationofengineersandchemistssustainabilitythinking fromthebeginning.
SustainableChemistryisacriticaltransformationinthe mannerinwhichweareconductingbusinessinthe pharmaceuticalindustry.Byadoptingitsprinciplesintothe fabricofmanufacturingoperations,wecanbuildafuture wherelife-savingdrugsaremadewithoutsacrificingthe healthofourplanet.It'snotjustagreenimperative—it'sa businessimperativethatunitesinnovation,stewardship,and resilience.
Withtheworldfacedwithunprecedentedglobalhealthand environmentalissues,doingtherightthingbyadopting SustainableChemistryisnolongeronlyethical—itis clever.
Syntheticbiologyhasbeenattheforefrontof multidisciplinarysciencesofthelasttenyears, combiningbiology,engineering,andcomputer scienceinordertodesignandconstructnewbiological systemsanddevices.Althoughitspossibleusespansawide rangeofindustries,fromagricultureandbioenergyto pharmaceuticals,itsmostrevolutionaryuseisinthe productionofmedicines.
Thenewtechnologyisrevolutionizingthedrugdiscovery, production,anddeliverybyofferingfaster,cleaner,and moreefficientsolutionstothetraditionalprocesses.
Thepharmasectorhaslongsufferedfromaccessproblems: lengthydrugdevelopmentprocess,appallinglyexorbitant expense,andquestionableoutcomes.Thetraditional methodofproducingdrugsischemicalsynthesisorplant extraction,bothofwhichareenergy-hungryand ecologicallyexpensive.Syntheticbiologyisabehemoth promisebecauseitenablesresearcherstodesign microbes—bacteria,yeast,andalgae—toproduce therapeuticmoleculesinexpensivelyandinbulk.
WithartificialDNAstrandsandnew-generationgenetic engineeringtoolslikeCRISPR,researcherscaninstruct cellstobehaveastinyfactoriesthatbuildcomplex moleculesthatareactivepharmaceuticalingredientsin mostmedicines.Apartfromsimplifyingthebiological engineeringprocess,italsofacilitatesthedevelopmentof newclassesofmedicines.
Oneofsyntheticbiology'sstrongestassetsisthatitcan speeduptheprocessofdiscoveringdrugs.Withthehelpof computationalmodelingandgenecircuitdesign,scientists canquicklyprototypeandscreendrugcandidates.The build-design-testparadigmcanbestreamlinedinlessthan thetimerequiredbytheoldtrial-and-errorstrategy.
Second,syntheticbiologycanscreenthousandsofgenetic constructsinhigh-throughputscreening,andscientistscan pickthebestlead-generatingdrugstrainsearlierinthe pipeline.Thatismoretargeteddrugdiscovery,whichcan resultinquickerdevelopmenttimesforlife-savingdrugsto market.
Oneoftheassetsofsyntheticbiologyisthatitpotentially canbeabletofacilitatebringingtheviabilityofproduction tobearonmakingitpossiblefordrugmanufacturingto becomefeasible.Traditionaldrugmanufacturetendstorely onthedepletionofscarcenaturalcommoditiesormultiplestepsynthesisprotocolstoyieldharmfulby-products. Syntheticbiologyhasthepotentialtomakepossiblethe biosynthesisofdrugsfromrenewablyavailablefeedstocks suchassugarorcropswaste.
Forinstance,theantimalarialartemisininwasonceonly availablefromthesupplychain-dependent,seasonalsweet wormwoodplant.Syntheticbiologynowallowsusto geneticallyengineeryeasttocreateartemisinicacid—the precursormoleculetoartemisinin—throughfermentation processesincontrolledconditions,givingastableand scalablesourceofthedrug.Notonlyisthischeaperforthe drug,butitalsoremovespressurefromnaturalecosystems.
Thefutureofsyntheticbiologyismuchmorethanthe conventionalsmall-moleculedrugs.Itisfuelingthe inventionofadvancedtherapieslikegenetherapies,cell therapies,andpersonalizedmedicine.Byengineeringcells thatareabletorecognizeandrespondtodiseasebiomarkers inrealtime,scientistsareabletoengineer"smart"drugs thatrespondtotheindividualneedsofthepatient.
CAR-Tcelltherapyisonesuchexample.InCAR-Tcell therapy,theimmunecellsofthepatientaregenetically modifiedtotargetanddestroycancercells.Synbio equipmentisutilizedincellengineeringinawaythatthe engineeredcellspossessincreasedtargetingcapability alongwithsafetyswitches,therebyattainingimproved treatmentoutcomeatthecostofreducedsideeffect production.
Also,syntheticbiologyenablesonetobuildandrapidly optimizemodularsystems.Itispossibletoadapttherapies toanindividual'sgeneticmakeup.Theapproachisvery promisingfortherapyoforphandiseasesandheretofore intractablediseases.
Syntheticbiologyisalsofindingaplaceinthevaccinearea. Traditionalvaccineproductionissluggishandtypically involvesculturingvirusesorbacteriaincellculture.
Syntheticbiologyallowsonetodesigngeneticconstructs againstpathogensandcreatevaccinemateriallikeantigens ormRNArapidlywithouttheuseoflivingorganisms.
ThespotlightduringtheCOVID-19pandemicwas providedbyit.mRNAvaccinesdevelopedbyorganizations likeModernaandBioNTech/Pfizerwerefacilitatedby syntheticbiologyplatformsthatprovidedquick developmentandscale-upofthevaccinemanufacturing. Thesametechnologiesareemployedtocombatother infectiousdiseaseswiththeadvantageofquickresponse timeandversatility
Whilepromising,syntheticbiologyisnotwithoutdanger. Makingchangestolivingorganismsatthislevelof precisionisveryseriousinsafety,regulatory,andethical terms.Thereisaconcernforunforeseeneffects,for instance,ofreleasinggeneticallyengineeredorganismsinto theenvironmentoroff-targetinhumantreatments.
Tocountersuchchallenges,policymakersandresearchers arelookingtoincorporatesaferegulationprocessesand biosecurity.Opennessandpublictrustwillalsobeessential inensuringconfidence-buildingandeffectivedevelopment ofsyntheticbiologyinnovationinmedicine.
Syntheticbiologyapplicationinmanufacturingmedicineis amedicalbehemoth.It'sefficient,precise,andgreenby usinginnovativedisease-treatmentmechanismsthatsome yearsagoexistedonlyinsci-fimovies.Astechnology becomesmoreadvancedeachday,wewillcontinue witnessingmoresophisticatedtechnologieslike programmablepills,biosensors,andon-demand pharmaceuticalproduction.
Briefly,syntheticbiologyisnotjustrevolutionizinghow medicinesareproduced—it'srevolutionizingwhatmedicine canaccomplish.Byblendingbiologyandengineering,itis imaginingaworldwheremedicinesdon'tjustfunction betterbutareaccessibletoallhumanbeingsonearth.The roadisonlybeginning,butthepotentialisimmensefor medicineintheyearstocome.
www.x.com/insightssuccess